Siegfried Holding AG
SFZN
Rang in Aktien
#4106
Siegfried Holding AG, together with its subsidiaries, engages in contract... Siegfried Holding AG, together with its subsidiaries, engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide. It offers drug substances, including exclusive synthesis that manufactures custom APIs. The company also offers an API portfolio, including non-exclusive APIs and pharma-grade substances that focus on anesthetics, pain and addiction treatment applications, and central nervous and respiratory diseases, as well as caffeine for human health and nutrition. In addition, it offers drug products, including steriles, which includes fill and finish in vials, ampoules, cartridges, and pre-filled syringes; ophthalmics, such as sterile ointments, gels, and suspensions and solutions; inhalation products, including capsules in medical devices for inhalation applications; oral solid dosage forms, which includes tablets and capsules; and viral vectors, such as AAV and lentiviruses for gene therapy. Further, the company provides technologies with chemistry capabilities, analytical services, formulation technologies, bridging technologies, containment technology, and cell and gene therapies. The company was founded in 1873 and is headquartered in Zofingen, Switzerland.
Aktienkurs
$88.34
Marktkapitalisierung
$3.87B
Veränderung (1 Tag)
1.68%
Veränderung (1 Jahr)
-12.97%
Land
CH
Handel Siegfried Holding AG (SFZN)
Kategorie
Healthcare
Gewinn für Siegfried Holding AG (SFZN)
Gewinn im 2026 TTM: 0
Laut den aktuellen Finanzberichten von Siegfried Holding AG betragen die aktuellen Gewinne des Unternehmens 0. Im Jahr 2026 erzielte das Unternehmen einen Gewinn von 0, gleich wie dem Gewinn im Jahr 2026, der 0 betrug. Die auf dieser Seite angezeigten Gewinne sind die Gewinne vor Zinsen und Steuern, auch bekannt als EBIT.
Gewinnverlauf von Siegfried Holding AG von 2002 bis 2026
Gewinn am Ende jedes Jahres
| Jahr | Gewinn | ändert |
|---|---|---|
| 2025 | $262.95M | 21.02% |
| 2024 | $217.28M | 21.51% |
| 2023 | $178.81M | -24.44% |
| 2022 | $236.63M | 70.46% |
| 2021 | $138.82M | 68.39% |
| 2020 | $82.44M | 54.98% |
| 2019 | $53.19M | -25.42% |
| 2018 | $71.32M | 20.14% |
| 2017 | $59.37M | 73.97% |
| 2016 | $34.13M | -7.94% |
| 2015 | $37.07M | 15.84% |
| 2014 | $32.00M | -43.19% |
| 2013 | $56.32M | 239.87% |
| 2012 | $16.57M | 48.10% |
| 2011 | $11.19M | -312.32% |
| 2010 | $-5.27M | -86.49% |
| 2009 | $-39.02M | -52.71% |
| 2008 | $-82.51M | -453.96% |
| 2007 | $23.31M | 6.35% |
| 2006 | $21.92M | -32.38% |
| 2005 | $32.41M | 96.31% |
| 2004 | $16.51M | -65.51% |
| 2003 | $47.87M | -4.28% |
| 2002 | $50.01M | 0.00% |
Gewinn ähnlicher Unternehmen oder Konkurrenten
| Unternehmen | Gewinn | Gewinnunterschied | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $1.76B | - |
IN
|
